Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$473,987
+$91,539 QoQ
Shares Held
1,967
-2.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#397
of 640 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $30,019,192 across 14 Biotechnology names. JAZZ ranks #5 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,423 | $14,615,286 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,459 | $7,145,144 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,556 | $4,381,792 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
14,598 | $516,623 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
1,967 | $473,987 | |
| 6 | EXEL |
Exelixis, Inc.
|
8,157 | $443,822 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
39,472 | $386,430 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,460 | $363,534 |
All Filings in JAZZ
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $473,987 | 1,967 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $382,448 | 2,023 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $343,910 | 2,023 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $286,137 | 2,171 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $230,386 | 2,171 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $269,529 | 2,171 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $286,939 | 2,330 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $278,636 | 2,501 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $266,931 | 2,501 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $320,196 | 2,659 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $339,972 | 2,764 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $385,990 | 2,982 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $387,902 | 3,129 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $457,866 | 3,129 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $498,480 | 3,129 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $417,064 | 3,129 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $488,155 | 3,129 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $487,091 | 3,129 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $398,634 | 3,129 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $407,427 | 3,129 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $555,835 | 3,129 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $480,946 | 2,926 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $482,936 | 2,926 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||